---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-003061"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2022-01-21T23:59:59+00:00"
generated_at: "2026-06-27T16:33:41.980663+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Hoth Therapeutics director Vadim Mats resigns from Board effective Jan 31, 2022

## Summary
- Director Vadim Mats informed the Company he will resign from the Board and its compensation and nominating/corporate governance committees.
- Resignation effective January 31, 2022; not due to any disagreement with the Company's operations, policies, management, or Board.
- No replacement has been announced; Board size will decrease by one member.

## SEC filing metadata
- accession: 0001213900-22-003061
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2022-01-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/0001213900-22-003061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/ea154246-8k_hoththerap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-003061
- JSON: https://secwatch.observer/filing/0001213900-22-003061.json
- Plain text: https://secwatch.observer/filing/0001213900-22-003061.txt

## Key facts
- Executive change
  Vadim Mats departed as Director at Hoth Therapeutics, Inc..
  - Action: resigning
  - Role: Director
  source text: On January 19, 2022, Vadim Mats informed Hoth Therapeutics, Inc. (the “Company”) that he will be resigning from the Company’s Board of Directors (the “Board”) as well as the Company’s compensation committee and nominating and corporate governance committee effective as of January 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711786/000121390022003061/0001213900-22-003061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.